Nektar to Announce Financial Results for the First Quarter 2021 on Thursday, May 6, 2021, After Close of U.S.-Based Financial Markets

Rhea-AI Summary

Nektar Therapeutics (Nasdaq: NKTR) will disclose its financial results for Q1 2021 on May 6, 2021, post-market close. CEO Howard Robin will lead a conference call at 5:00 p.m. ET to discuss these results. Investors can access the press release and live audio webcast on the Nektar website. The conference call can be reached by dialing (877) 881-2183 for U.S. callers or (970) 315-0453 for international attendees, with a Conference ID of 9233368. The recorded webcast will be available for replay until May 27, 2021.

SAN FRANCISCO, April 27, 2021 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the first quarter 2021 on Thursday, May 6, 2021, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.

The press release and live audio-only webcast of the conference call can be accessed through a link that is posted on the Home Page and Investors section of the Nektar website: http://ir.nektar.com/. The web broadcast of the conference call will be available for replay through Thursday, May 27, 2021.

To access the conference call, follow these instructions:

Dial: (877) 881-2183 (U.S.); (970) 315-0453 (international)
Conference ID: 9233368 (Nektar Therapeutics is the host)

About Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

Contacts:

For Investors:
Vivian Wu of Nektar Therapeutics
628-895-0661

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/nektar-to-announce-financial-results-for-the-first-quarter-2021-on-thursday-may-6-2021-after-close-of-us-based-financial-markets-301278444.html

SOURCE Nektar Therapeutics

FAQ

When will Nektar Therapeutics announce its Q1 2021 financial results?

Nektar Therapeutics will announce its Q1 2021 financial results on May 6, 2021.

What time is the Nektar Therapeutics conference call for Q1 2021 results?

The conference call will be held at 5:00 p.m. Eastern Time on May 6, 2021.

How can I access the Nektar Therapeutics conference call?

You can access the conference call by dialing (877) 881-2183 for U.S. or (970) 315-0453 for international calls, using Conference ID 9233368.

Where can I find the webcast of the Nektar Therapeutics conference call?

The webcast can be found on the Nektar website in the Investor section.

How long will the Nektar Therapeutics conference call replay be available?

The recorded webcast will be available for replay until May 27, 2021.